Susan Rudders, MD
Immunologist, Division of Immunology
Assistant Professor, Harvard Medical School
Image
Susan Rudders, MD
Immunologist, Division of Immunology
Assistant Professor, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
University of Massachusetts Medical School
2004
Worcester
MA
Residency
Pediatrics
Brown University
2007
Providence
RI
Fellowship
Allergy/Immunology
Boston Children's Hospital
2010
Boston
MA
Certifications
American Board of Allergy & Immunology (General)
Publications
Friends, Family, and Food: Development of a Food Allergy Intervention, F3-App, for Children. View Abstract
No allergy left behind: The importance of food allergy in longitudinal cohorts. View Abstract
Anaphylaxis knowledge gaps and future research priorities: A consensus report. View Abstract
Early Introduction of Food Allergens and Risk of Developing Food Allergy. View Abstract
Emergency department revisits and rehospitalizations among infants and toddlers for acute allergic reactions. View Abstract
Emerging Therapies in Anaphylaxis: Alternatives to Intramuscular Administration of Epinephrine. View Abstract
Trends in US Emergency Department Visits for Anaphylaxis Among Infants and Toddlers: 2006-2015. View Abstract
Severity grading system for acute allergic reactions: A multidisciplinary Delphi study. View Abstract
Allergic sensitization during early life: Concordance between ImmunoCAP and ISAC results. View Abstract
Trends in US hospitalizations for anaphylaxis among infants and toddlers: 2006 to 2015. View Abstract
Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study. View Abstract
Epinephrine in the Management of Anaphylaxis. View Abstract
Inpatient interventions are infrequent during pediatric hospitalizations for food-induced anaphylaxis. View Abstract
Utility of ICD-9-CM Codes for Identification of Allergic Drug Reactions. View Abstract
Sunlight, vitamin D and food allergy. View Abstract
Topical Review: Pediatric Food Allergies Among Diverse Children. View Abstract
Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. View Abstract
Trends in hospitalizations for food-induced anaphylaxis in US children, 2000-2009. View Abstract
Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. View Abstract
Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up. View Abstract
Favorable trends in the frequency of U.S. emergency department visits for food allergy, 2001-2009. View Abstract
An update on self-injectable epinephrine. View Abstract
Longitudinal study of 954 patients with stinging insect anaphylaxis. View Abstract
National survey of pediatric services available in US emergency departments. View Abstract
Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. View Abstract
Predictors of hospital admission for food-related allergic reactions that present to the emergency department. View Abstract
Frequency of US emergency department visits for food-related acute allergic reactions. View Abstract
Age-related differences in the clinical presentation of food-induced anaphylaxis. View Abstract
Season of birth and food-induced anaphylaxis in Boston. View Abstract
Trends in pediatric emergency department visits for food-induced anaphylaxis. View Abstract
Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department. View Abstract
Repeat epinephrine treatments for food-related allergic reactions that present to the emergency department. View Abstract
North-south differences in US emergency department visits for acute allergic reactions. View Abstract
Season of birth and food allergy in children. View Abstract
Multicenter study of repeat epinephrine treatments for food-related anaphylaxis. View Abstract
Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. View Abstract
Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. View Abstract
ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. View Abstract